A psychiatrist is expected to be struck off this weekend after being found guilty of conducting unethical drug tests on mentally ill patients.

Tonmoy Sharma, a former lecturer at the Institute of Psychiatry, wrongly recruited patients in unsolicited telephone calls without contacting their nurses or carers, the General Medical Council has found. After being paid to conduct the tests by drug companies, he failed to seek proper approval from medical bodies and then misled the companies about his methods.

He also wrongly described himself as being a professor and falsely claimed that he had a PhD.

The General Medical Council ruling, which examined Dr Sharma’s research over ten years, could force the pharmaceutical industry to reexamine the way in which research on psychiatric drugs is commissioned and conducted.

A report by the GMC’s Fitness To Practise panel concluded this week that Dr Sharma had put mentally unwell patients at risk and ethical rules had been wilfully flouted.

“The findings of the panel indicate serious failings of personal integrity and honesty, of good clinical research practice, as regards to potential welfare of patients and participants in ethical research . . . which risks bringing the reputation of the medical profession into disrepute.

“The panel has found that the facts proved against you would not be insufficient to support a finding of serious professional misconduct,” it reads.

Dr Sharma, 42, who trained in India, was a prominent psychiatrist who often appeared on the BBC and wrote books on mental illness.

Leading drug companies such as Novartis and Sanofi paid him from 1996 to conduct trials of antipsychotic drugs on patients with schizophrenia and Alzheimer’s disease.

He worked as a consultant psychiatrist for the South London and Maudsley NHS Trust and recruited patients in Kent and parts of the capital for the research, according to reports.

His position at the institute helped him to secure funding, said to be almost £1 million, from five drug companies. Most of the money was channelled through a private company that he had set up called Psychmed.

The Association of the British Pharmaceutical Industry asked the GMC to examine his conduct two years ago after concerns that he had failed to obtain proper approval from ethical committees to conduct the tests.

These approvals are vital in any trial to protect the patients taking part.

The panel found that during 2003 patients were recruited to Dr Sharma’s studies by telephone and without any contact with their GPs or psychiatric nurse of carer, and without adequate information about the tests themselves. This was unprofessional, risked patient care and risked patient welfare, the GMC concluded.

On a number of occasions, Dr Sharma failed to obtain approval from proper ethical committees before testing drugs on patients.

The companies that paid for the research were also misled, according to the GMC report. Dr Sharma was commissioned to conduct work by the drug company Eli Lilly and the Janssen Research Foundation. He instead chose to use identical patients for both studies and tried to conceal this from the bodies. As a result some patients underwent MRI scans and tests that had not been approved by the patients or by an ethics committee.

“The panel is satisfied that in acting the way you did your intention was to conceal from each sponsor the fact that you were using the identical group of patients for their studies,” the report says. “As a consequence, the patients were subjected to tests beyond those approved . . . The panel is satisfied that your conduct towards them [the companies] was dishonest. It was also unprofessional and not in the best interests of the study patients.”

In April 1999 Dr Sharma became the main investigator for a study on behalf of Novartis into the effect of the Alzheimer’s drug Exelon.

The GMC found that Dr Sharma generated a misunderstanding that the Novartis study was affiliated to the Institute of Psychiatry. He also tried to disguise that the research was being conducted by his company Psychmed, not the institute.

The GMC’s panel will consider today whether Dr Sharma is guilty of serious professional misconduct. Insiders say that he can expect to be struck off the medical register.

Mr Sharma, who represented himself during the GMC hearing, could not be contacted yesterday.

Explore Health News

• Swine flu

Times Recommends

• The bright side of this winter rain
• Story behind the picture: Snow Leopard, 2008
• Times Charity Appeal: The Place2Be